N-Acetylcysteine, #NAC #earlytreatment #therapeutics
Inhalation of Vapor with Medication (Diclofenac Sodium, Menthol, Methyl Salicylate and N-Acetyl Cysteine) Reduces Oxygen Need and Hospital Stay in COVID-19 Patients – A Case Control Study
N-Acetylcysteine to Combat COVID-19: An Evidence Review
N-acetyl cysteine: A tool to perturb SARS-CoV-2 spike protein conformation
N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspective on the Current State of the Evidence
N-Acetylcysteine to Combat COVID-19: An Evidence Review
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
N-acetylcysteine: A rapid review of the evidence for effectiveness in treating COVID-19
A Study of N-acetylcysteine in Patients with COVID19 Infection
N-acetylcysteine as a potential treatment for COVID-19
N-Acetylcysteine and Hydrogen Sulfide in Coronavirus Disease 2019
Case Report: Use of hydroxychloroquine and N-acetylcysteine for treatment of a COVID-19 patient [version 2; peer review: 2 not approved]
Studies show N-Acetyl Cysteine supplement can possibly protect patients against COVID-19
Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19
Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial
N-acetylcysteine in Severe COVID-19: The Possible Mechanism
Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: review of current evidence
Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Experience of N-acetylcysteine airway management in the successful treatment of one case of critical condition with COVID-19
Inhalation of Vapor with Medication (Diclofenac Sodium, Menthol, Methyl Salicylate and N-Acetyl Cysteine) Reduces Oxygen Need and Hospital Stay in COVID-19 Patients – A Case Control Study
N-Acetylcysteine to Combat COVID-19: An Evidence Review
N-acetyl cysteine: A tool to perturb SARS-CoV-2 spike protein conformation
N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspective on the Current State of the Evidence
N-Acetylcysteine to Combat COVID-19: An Evidence Review
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
The efficacy of N-Acetylcysteine in severe COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
N-acetylcysteine: A rapid review of the evidence for effectiveness in treating COVID-19
A Study of N-acetylcysteine in Patients with COVID19 Infection
N-acetylcysteine as a potential treatment for COVID-19
N-Acetylcysteine and Hydrogen Sulfide in Coronavirus Disease 2019
Case Report: Use of hydroxychloroquine and N-acetylcysteine for treatment of a COVID-19 patient [version 2; peer review: 2 not approved]
Studies show N-Acetyl Cysteine supplement can possibly protect patients against COVID-19
Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19
Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial
N-acetylcysteine in Severe COVID-19: The Possible Mechanism
Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: review of current evidence
Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Experience of N-acetylcysteine airway management in the successful treatment of one case of critical condition with COVID-19
jmscr.igmpublication.org
Inhalation of Vapor with Medication (Diclofenac Sodium, Menthol, Methyl Salicylate and N-Acetyl Cysteine) Reduces Oxygen Need and…
Media is too big
VIEW IN TELEGRAM
Joe Rogan on overreaching governments and their natural inclination to gravitate towards tyranny if left unchecked
4_5959601963145364139.pdf
160.8 KB
The FDA has ordered Pfizer to perform studies on the side effects of their bioagent "vaccine" on children's hearts (Myocarditis).
THE STUDIES WILL BE COMPLETED IN MAY 2027.
2027.
Yet they're going to "vaccinate" kids in meantime.
SOURCE: (pg 8)
THE STUDIES WILL BE COMPLETED IN MAY 2027.
2027.
Yet they're going to "vaccinate" kids in meantime.
SOURCE: (pg 8)
Media is too big
VIEW IN TELEGRAM
Del Bigtree, from The High Wire, issues a dire warning to the world as he discusses the legitimate concern of Antibody Dependent Enhancement (ADE) with COVID-19 'investigational vaccines' and the implications of a worldwide 'vaccine' rollout amongst the global populace without proper clinical trials to study the long-term effects of mRNA vaccine technology.
additional ADE resources:
[01], [02], [03], [04], [05], [06], [07]
#DelBigtree #video
additional ADE resources:
[01], [02], [03], [04], [05], [06], [07]
#DelBigtree #video
"On these bases, a study was planned in 30 COVID19-infected patients with initial or important symptomatology, 16 of whom orally treated by MLT (20 mg/day in the evening) plus cannabidiol (CBD) (10 mg x 2/day) only, while the other 14 patients received also Ang 1-7 (0.5 mg 2/day orally). The results were compared to those observed in a control group of 30 COVID-19 infected patient, who received the only supportive therapy. No hospitalisation for initial respiratory failure was required in the group of patients treated by the neuroimmune regimen. In addition, most patients referred a rapid disappearance of fever and myalgia, as well as a relief of asthenia, particularly in those concomitantly treated with Ang 1-7. On the contrary, 5/30 (17%) control patients required hospitalisation. The difference was statistically significant (0/30 vs 5/30, P< 0.05). This preliminary study would suggest that a neuroimmune approach consisting of MLT and CBD in association with Ang 1-7 is an effective and non-toxic regimen in the therapy of COVID19-related symptoms, which could also control the clinical evolution of disease and reduce the need of hospitalisation."
beta amyloid plaques in brain following vaccination confirmed by PET scan.
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8439537/
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8439537/
PubMed Central (PMC)
Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination
Large-scale worldwide COVID-19 vaccination programs are being rapidly deployed, and high-risk patients with comorbidity are now receiving the first doses of the vaccine. Physicians should be, therefore, aware of new pitfalls associated with the current ...
NEJM humiliatingly retracted a major, policy-changing study last year because it was completely fabricated. Now they subtly publish a correction about safety of vaccines in pregnancy.
#NEJM published a correction... they now admit that there is no evidence that the vaccines are safe for pregnant women. Whoops. Look for the "1" at the VERY top of the page.
https://www.nejm.org/doi/full/10.1056/nejme2107070
In short, the CDC has no basis to recommend the vaccine to pregnant women. Will lack of evidence make a difference in the CDC recommendation? Of course not. We'll experiment on the public. They wouldn't make this correction unless they had evidence it's actually detrimental, me thinks.
#NEJM published a correction... they now admit that there is no evidence that the vaccines are safe for pregnant women. Whoops. Look for the "1" at the VERY top of the page.
https://www.nejm.org/doi/full/10.1056/nejme2107070
In short, the CDC has no basis to recommend the vaccine to pregnant women. Will lack of evidence make a difference in the CDC recommendation? Of course not. We'll experiment on the public. They wouldn't make this correction unless they had evidence it's actually detrimental, me thinks.
The New England Journal of Medicine
mRNA Covid-19 Vaccines in Pregnant Women | NEJM
After Emergency Use Authorization was granted for the messenger RNA (mRNA) vaccines
BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna), persons at the highest risk for
coronavirus disease 2019 (Cov...
BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna), persons at the highest risk for
coronavirus disease 2019 (Cov...
FLCCC and Allied Publications
#MATH+ protocol for the treatment of SARS-CoV-2 infection: The scientific rationale https://flccc.net/math-protocol-for-the-treatment-of-sars-cov-2-infection-the-scientific-rationale/
SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’ (published in the BMJ Open Respiratory Research, September 22, 2020). https://www.youtube.com/watch?v=bJZcDBTEGio
COVID-19: A Clinician’s Perspective: A master-class comprehensive review by Dr. Paul Marik of scientific insights into the origin, replication, transmission, infectivity, pathophysiology, and treatment of COVID-19. (USA, September 25, 2020).
Information about the #MATH+ protocol and the medicines used can be found in our peer-reviewed paper Clinical and Scientific Rationale for the MATH+ Hospital Treatment Protocol for COVID-19 (published in the Journal of Intensive Care Medicine, December 2020). https://flccc.net/math-plus-rationale-journal-of-intensive-care-medicine-dec2020/
Our review of Ivermectin: Review of the Emerging Evidence Supporting the Use of #Ivermectin in the #Prophylaxis and #Treatment of COVID-19 – November 2020. also see our Ivermectin in COVID-19 section. https://flccc.net/flccc-ivermectin-in-the-prophylaxis-and-treatment-of-covid-19/ + https://covid19criticalcare.com/ivermectin-in-covid-19/
A “Summary of the Evidence for #Ivermectin in COVID-19”: FLCCC Alliance Review: Ivermectin in prevention and treatment of COVID-19. https://covid19criticalcare.com/wp-content/uploads/2021/08/SUMMARY-OF-THE-EVIDENCE-BASE.pdf
Global trends in clinical studies of #ivermectin in COVID-19: Dr. Satoshi Ōmura, co-author of the newly published paper, “Global trends in clinical studies of ivermectin in COVID-19” was one of the four researchers from Kitasato University in Tokyo, Japan who received the Nobel Prize in Physiology or Medicine in 2015 for their discovery of ivermectin. (published April 5, 2021). https://flccc.net/wp-content/uploads/2021/04/Satoshi-Omura-Global-trends-in-clinical-studies-of-ivermectin-in-COVID-19-Japanese-Journal-of-Antibiotics-March-10-2021.pdf
Our peer-reviewed paper on Ivermectin: Review of the Emerging Evidence Demonstrating the Efficacy of #Ivermectin in the #Prophylaxis and #Treatment of COVID-19. (published in the American Journal of Therapeutics, May 2021). https://journals.lww.com/americantherapeutics/Fulltext/2021/06000/Review_of_the_Emerging_Evidence_Demonstrating_the.4.aspx
Bryant, Lawrie et al Meta-analysis of Ivermectin: #Ivermectin for #Prevention and #Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. (American Journal of Therapeutics, June 2021). Authors’ Update https://covid19criticalcare.com/wp-content/uploads/2021/06/Ivermectin_for_Prevention_and_Treatment_of.98040.pdf
Andrew Hill, et al: Meta-analysis of ivermectin by the WHO research team: Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 Infection. (Published by Oxford University Press on behalf of Infectious Diseases Society of America, July 2021). https://covid19criticalcare.com/wp-content/uploads/2021/07/AndrewHill7-6-21paper.pdf
Marik, Paul, et al: Researching the different clinical stages of COVID 19 and pinpointing the treatment needed for each stage: A Scoping Review of the Pathophysiology of COVID-19. (Published by The International Journal of Immunopathology & Pharmacology, September 2021). https://covid19criticalcare.com/wp-content/uploads/2021/09/Covid-Pathophysiology.pdf
#MATH+ protocol for the treatment of SARS-CoV-2 infection: The scientific rationale https://flccc.net/math-protocol-for-the-treatment-of-sars-cov-2-infection-the-scientific-rationale/
SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’ (published in the BMJ Open Respiratory Research, September 22, 2020). https://www.youtube.com/watch?v=bJZcDBTEGio
COVID-19: A Clinician’s Perspective: A master-class comprehensive review by Dr. Paul Marik of scientific insights into the origin, replication, transmission, infectivity, pathophysiology, and treatment of COVID-19. (USA, September 25, 2020).
Information about the #MATH+ protocol and the medicines used can be found in our peer-reviewed paper Clinical and Scientific Rationale for the MATH+ Hospital Treatment Protocol for COVID-19 (published in the Journal of Intensive Care Medicine, December 2020). https://flccc.net/math-plus-rationale-journal-of-intensive-care-medicine-dec2020/
Our review of Ivermectin: Review of the Emerging Evidence Supporting the Use of #Ivermectin in the #Prophylaxis and #Treatment of COVID-19 – November 2020. also see our Ivermectin in COVID-19 section. https://flccc.net/flccc-ivermectin-in-the-prophylaxis-and-treatment-of-covid-19/ + https://covid19criticalcare.com/ivermectin-in-covid-19/
A “Summary of the Evidence for #Ivermectin in COVID-19”: FLCCC Alliance Review: Ivermectin in prevention and treatment of COVID-19. https://covid19criticalcare.com/wp-content/uploads/2021/08/SUMMARY-OF-THE-EVIDENCE-BASE.pdf
Global trends in clinical studies of #ivermectin in COVID-19: Dr. Satoshi Ōmura, co-author of the newly published paper, “Global trends in clinical studies of ivermectin in COVID-19” was one of the four researchers from Kitasato University in Tokyo, Japan who received the Nobel Prize in Physiology or Medicine in 2015 for their discovery of ivermectin. (published April 5, 2021). https://flccc.net/wp-content/uploads/2021/04/Satoshi-Omura-Global-trends-in-clinical-studies-of-ivermectin-in-COVID-19-Japanese-Journal-of-Antibiotics-March-10-2021.pdf
Our peer-reviewed paper on Ivermectin: Review of the Emerging Evidence Demonstrating the Efficacy of #Ivermectin in the #Prophylaxis and #Treatment of COVID-19. (published in the American Journal of Therapeutics, May 2021). https://journals.lww.com/americantherapeutics/Fulltext/2021/06000/Review_of_the_Emerging_Evidence_Demonstrating_the.4.aspx
Bryant, Lawrie et al Meta-analysis of Ivermectin: #Ivermectin for #Prevention and #Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. (American Journal of Therapeutics, June 2021). Authors’ Update https://covid19criticalcare.com/wp-content/uploads/2021/06/Ivermectin_for_Prevention_and_Treatment_of.98040.pdf
Andrew Hill, et al: Meta-analysis of ivermectin by the WHO research team: Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 Infection. (Published by Oxford University Press on behalf of Infectious Diseases Society of America, July 2021). https://covid19criticalcare.com/wp-content/uploads/2021/07/AndrewHill7-6-21paper.pdf
Marik, Paul, et al: Researching the different clinical stages of COVID 19 and pinpointing the treatment needed for each stage: A Scoping Review of the Pathophysiology of COVID-19. (Published by The International Journal of Immunopathology & Pharmacology, September 2021). https://covid19criticalcare.com/wp-content/uploads/2021/09/Covid-Pathophysiology.pdf
Forwarded from T C
https://www.law.cornell.edu/wex/mandamus#:~:text=A%20(writ%20of)%20mandamus%20is,367%20(2004)%20334%20F
So far 28 states have filed against their governors.
We expect 35 by this weekend.
We now have a super majority and can take it to the Supreme Court.
I recommend reading through your state constitution also. They like and have been changing laws for decades to set this up. Most are for mandating face diapers and vaccines. It is unlawful to mandate when under an EUA.
The EUA put in effect for the pharma companies runs out in 2023.
Here is the reading material.
https://www.naturalnews.com/2021-05-23-federal-law-prohibits-mandates-of-emergency-use-covid-vaccines.html
Both links are wonderul.
So far 28 states have filed against their governors.
We expect 35 by this weekend.
We now have a super majority and can take it to the Supreme Court.
I recommend reading through your state constitution also. They like and have been changing laws for decades to set this up. Most are for mandating face diapers and vaccines. It is unlawful to mandate when under an EUA.
The EUA put in effect for the pharma companies runs out in 2023.
Here is the reading material.
https://www.naturalnews.com/2021-05-23-federal-law-prohibits-mandates-of-emergency-use-covid-vaccines.html
Both links are wonderul.
LII / Legal Information Institute
mandamus
new Karen Kingston
https://usawatchdog.com/unvaxed-at-risk-from-vaxed-in-coming-dark-winter-karen-kingston/
https://usawatchdog.com/unvaxed-at-risk-from-vaxed-in-coming-dark-winter-karen-kingston/
Usawatchdog
Unvaxed at Risk from Vaxed in Coming Dark Winter – Karen Kingston | Greg Hunter’s USAWatchdog
By Greg Hunter’s USAWatchdog.com Karen Kingston is a medical analyst that researches a wide variety of things in the medical world. She’s an expert in getting new drugs and medical devices approved and pass regulatory hurdles. She researched the drug patents…